Blackrock Pharmaceuticals Limited

POWER SEARCH PRICING

SOLUTIONS

blackrock pharmaceuticals limited Company Information

Live

EstablishedSmallDeclining

Company Number

06458588

Website

www.blackrockpharmaceuticals.co.uk

Registered Address

the old barrel store, draymans lane, marlow, buckinghamshire, SL7 2FF

Industry

Manufacture of pharmaceutical preparations

Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.

Telephone

01628860333

Next Accounts Due

September 2024

Group Structure

View All

Directors

Una Loughrey16 Years

Desmond McMahon16 Years

View All

Shareholders

peter griffin & una loughrey 44.2%

mr stephen loughrey & mrs suzanne loughrey 20%

View All

blackrock pharmaceuticals limited Estimated Valuation

£496.6k

Pomanda estimates the enterprise value of BLACKROCK PHARMACEUTICALS LIMITED at £496.6k based on a Turnover of £709.3k and 0.7x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Blackrock Pharmaceuticals Limited is a live company located in marlow, SL7 2FF with a Companies House number of 06458588. It operates in the manufacture of pharmaceutical preparations sector, SIC Code 21200. Founded in December 2007, it's largest shareholder is peter griffin & una loughrey with a 44.2% stake. Blackrock Pharmaceuticals Limited is a established, small sized company, Pomanda has estimated its turnover at £709.3k with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Blackrock Pharmaceuticals Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs

Health Rating2.5out of 5

2 Strong

4 Regular

6 Weak

Size

annual sales of £709.3k, make it smaller than the average company (£13.2m)

Growth

3 year (CAGR) sales growth of -23%, show it is growing at a slower rate (3.2%)

EXPORT

Blackrock Pharmaceuticals Limited's latest turnover from December 2022 is estimated at £709.3 thousand and the company has net assets of -£1.2 million. According to their latest financial statements, Blackrock Pharmaceuticals Limited has 4 employees and maintains cash reserves of £83.9 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Turnover	709,278	1,333,591	1,795,058	1,541,507	2,533,554	727,737	573,438	562,939	1,124,085	536,935	10,219	0	0	0
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	430,818	803,319	1,064,621	899,412	1,438,625	396,888	310,633	313,684	652,466	311,288	6,174	0	0	0
Gross Profit	278,460	530,272	730,437	642,095	1,094,930	330,849	262,804	249,255	471,619	225,647	4,045	0	0	0
Admin Expenses	386,279	816,551	692,217	861,011	1,364,230	472,419	543,200	496,529	354,607	-391,107	120,013	160,609	40,984	123,743
Operating Profit	-107,819	-286,279	38,220	-218,916	-269,300	-141,570	-280,396	-247,274	117,012	616,754	-115,968	-160,609	-40,984	-123,743
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0	4,751	4,751
Interest Receivable	3,021	423	191	1,118	981	571	407	1,501	1,092	188	159	65	51	32
Pre-Tax Profit	-104,798	-285,856	38,411	-217,798	-268,319	-140,999	-279,989	-245,773	118,104	616,942	-115,809	-160,544	-45,684	-128,461
Tax	0	0	-7,298	0	0	0	0	0	-24,802	-141,897	0	0	0	0
Profit After Tax	-104,798	-285,856	31,113	-217,798	-268,319	-140,999	-279,989	-245,773	93,302	475,045	-115,809	-160,544	-45,684	-128,461
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-104,798	-285,856	31,113	-217,798	-268,319	-140,999	-279,989	-245,773	93,302	475,045	-115,809	-160,544	-45,684	-128,461
Employee Costs	210,383	204,727	200,556	248,555	239,151	230,907	229,065	225,458	317,515	174,591	41,258	0	0	0
Number Of Employees	4	4	4	5	5	5	5	5	7	4	1	0	0	0
EBITDA*	-107,177	-285,305	39,588	-218,916	-260,658	-132,809	-272,949	-246,024	117,349	616,754	-115,968	-160,609	-40,984	-123,743

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Tangible Assets	464	1,105	2,079	1,687	3,350	11,647	18,513	5,693	2,703	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	464	1,105	2,079	1,687	3,350	11,647	18,513	5,693	2,703	0	0	0	0	0
Stock & work in progress	34,012	180,845	385,345	306,852	540,210	39,236	17,428	0	0	0	0	0	0	0
Trade Debtors	131,220	263,339	230,572	146,101	338,627	111,978	65,764	28,177	83,050	83,475	1,543	0	0	4,800
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	57,007	65,484	242,603	137,474	182,346	86,962	108,787	85,458	0	0	0	0	90	0
Cash	83,938	88,696	249,770	132,543	165,481	96,134	132,148	193,775	406,430	30,187	44,894	18,587	7,477	12,913
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	306,177	598,364	1,108,290	722,970	1,226,664	334,310	324,127	307,410	489,480	113,662	46,437	18,587	7,567	17,803
total assets	306,641	599,469	1,110,369	724,657	1,230,014	345,957	342,640	313,103	492,183	113,662	46,437	18,587	7,567	17,803
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	151,473	343,565	631,949	561,368	931,081	216,892	160,345	136,238	374,244	89,025	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	496,845	353,186	181,622	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	146,174
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	1,349,638	1,345,576	1,282,236	1,198,218	1,116,064	677,877	590,108	304,699	0	0	0	0	0	0
total current liabilities	1,501,111	1,689,141	1,914,185	1,759,586	2,047,145	894,769	750,453	440,937	374,244	89,025	496,845	353,186	181,622	146,174
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total liabilities	1,501,111	1,689,141	1,914,185	1,759,586	2,047,145	894,769	750,453	440,937	374,244	89,025	496,845	353,186	181,622	146,174
net assets	-1,194,470	-1,089,672	-803,816	-1,034,929	-817,131	-548,812	-407,813	-127,834	117,939	24,637	-450,408	-334,599	-174,055	-128,371
total shareholders funds	-1,194,470	-1,089,672	-803,816	-1,034,929	-817,131	-548,812	-407,813	-127,834	117,939	24,637	-450,408	-334,599	-174,055	-128,371

	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Operating Activities
Operating Profit	-107,819	-286,279	38,220	-218,916	-269,300	-141,570	-280,396	-247,274	117,012	616,754	-115,968	-160,609	-40,984	-123,743
Depreciation	642	974	1,368	0	8,642	8,761	7,447	1,250	337	0	0	0	0	0
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	0	0	-7,298	0	0	0	0	0	-24,802	-141,897	0	0	0	0
Stock	-146,833	-204,500	78,493	-233,358	500,974	21,808	17,428	0	0	0	0	0	0	0
Debtors	-140,596	-144,352	189,600	-237,398	322,033	24,389	60,916	30,585	-425	81,932	1,543	-90	-4,710	4,800
Creditors	-192,092	-288,384	70,581	-369,713	714,189	56,547	24,107	-238,006	285,219	89,025	0	0	0	0
Accruals and Deferred Income	4,062	63,340	84,018	82,154	438,187	87,769	285,409	304,699	0	0	0	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	-7,778	-161,497	-81,204	-35,719	68,711	-34,690	-41,777	-209,916	378,191	481,950	-117,511	-160,519	-36,274	-128,543
Investing Activities
capital expenditure	-1	0	-1,760	1,663	-345	-1,895	-20,267	-4,240	-3,040	0	0	0	0	0
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-1	0	-1,760	1,663	-345	-1,895	-20,267	-4,240	-3,040	0	0	0	0	0
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	-496,845	143,659	171,564	181,622	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	-146,174	146,174
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	0	0	200,000	0	0	0	10	0	0	0	0	0	0	90
interest	3,021	423	191	1,118	981	571	407	1,501	1,092	188	159	65	-4,700	-4,719
cash flow from financing	3,021	423	200,191	1,118	981	571	417	1,501	1,092	-496,657	143,818	171,629	30,748	141,545
cash and cash equivalents
cash	-4,758	-161,074	117,227	-32,938	69,347	-36,014	-61,627	-212,655	376,243	-14,707	26,307	11,110	-5,436	12,913
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	-4,758	-161,074	117,227	-32,938	69,347	-36,014	-61,627	-212,655	376,243	-14,707	26,307	11,110	-5,436	12,913

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for blackrock pharmaceuticals limited. Get real-time insights into blackrock pharmaceuticals limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for blackrock pharmaceuticals limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

BLACKROCK PHARMACEUTICALS LIMITED group structure

Blackrock Pharmaceuticals Limited has no subsidiary companies.

Ultimate parent company

BLACKROCK PHARMACEUTICALS LIMITED

06458588

BLACKROCK PHARMACEUTICALS LIMITED Shareholders

peter griffin & una loughrey	44.17%
mr stephen loughrey & mrs suzanne loughrey	20%
philip mcferran	12.5%
desmond mcmahon	12.5%
rupert adam john davies	10.83%

Blackrock Pharmaceuticals Limited currently has 5 directors. The longest serving directors include Mrs Una Loughrey (Dec 2007) and Mr Desmond McMahon (Dec 2007).

officer	country	age	start	end	role
Mrs Una Loughrey		55 years	Dec 2007	-	Director
Mr Desmond McMahon		58 years	Dec 2007	-	Director
Mr Philip McFerran	England	56 years	Dec 2007	-	Director
Mr Peter Griffin		55 years	Dec 2007	-	Director
Mr Rupert Davies	England	56 years	Oct 2015	-	Director

P&L

December 2022

turnover

709.3k

-47%

operating profit

-107.8k

gross margin

39.3%

-1.27%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2022

net assets

-1.2m

+0.1%

total assets

306.6k

-0.49%

cash

83.9k

-0.05%

net assets

Total assets minus all liabilities

Similar Companies

Agree?

paradigm procurement ltd

porterhouse medical limited

3.5

gable consultancy limited

brentway ventures limited

willis publicity (harpenden) limited

3.5

company number

06458588

Type

Private limited with Share Capital

industry

21200 - Manufacture of pharmaceutical preparations

74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.

incorporation date

December 2007

age

accounts

Total Exemption Full

ultimate parent company

None

previous names

N/A

incorporated

address

the old barrel store, draymans lane, marlow, buckinghamshire, SL7 2FF

last accounts submitted

December 2022

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to blackrock pharmaceuticals limited.

blackrock pharmaceuticals limited Company Information

blackrock pharmaceuticals limited Estimated Valuation

blackrock pharmaceuticals limited Estimated Valuation

blackrock pharmaceuticals limited Estimated Valuation

Blackrock Pharmaceuticals Limited Overview

Blackrock Pharmaceuticals Limited Health Check

BLACKROCK PHARMACEUTICALS LIMITED financials

blackrock pharmaceuticals limited Credit Report and Business Information

Blackrock Pharmaceuticals Limited Competitor Analysis

blackrock pharmaceuticals limited Ownership

blackrock pharmaceuticals limited directors

blackrock pharmaceuticals limited company details

blackrock pharmaceuticals limited Charges & Mortgages

blackrock pharmaceuticals limited Companies House Filings - See Documents